Thursday, July 13
Armstrong tired of incessant doping talk
 
 By Andrew Hood
ABC Sports Online

FUTUROSCOPE, France -- Racers in the 2000 Tour de France will face a new doping test during the race. Urine samples taken during the event will be saved for testing once an expert panel approves a new test to detect the banned hormone EPO.
 
  Lance Armstrong prefers talking about cycling than about doping.

The International Cycling Union, cycling's governing body, said it conditionally approved the test so the Tour will start smoothly. Tour de France race officials had hoped to use the proposed urine test during the race, but the UCI said it needed more time to review it for accuracy. The urine test was designed by France's national doping lab. Racers found with traces of EPO could still face sanctions after the race is long over.

Defending champion Lance Armstrong says he's sick and tired of questions about doping in cycling, but he answered them anyway in a press conference on Thursday.

"I prefer to talk about sport. I'm sick of this myth of widespread doping in cycling." Said the 1999 TDF champion. "It has always existed in all sports, but for some reason cycling has been singled out."

The Tour de France was saddled by crisis during the 1998 race when one of the top teams was caught with performance-enhancing drugs in a team car. The scandal blew open the cover on doping among the ranks of professional cycling and nearly derailed the 1998 Tour. Several teams were kicked out and others left in protest.

Last year, many critics insisted Armstrong's dominant performance had to be linked to doping. Although Armstrong has never failed blood or urine tests during his career, he was dogged by questions and innuendo.

"Whatever the UCI can do within their legal means to fight doping, they should do it," said Armstrong. "There's no easy answer to doping. I can't tell you the answer. Cycling is a sport that's doing everything it can to fight doping. I prefer to work with the sport and not to destroy it."

On Friday, Tour de France director general Jean Marie Leblanc said this year's race is critical to the future of cycling.

"The renewal and future of the sport is one the line starting tomorrow. The new test is being used to eliminate the suspicion between riders and with the public," said Leblanc in an address to all the riders. "The net is closing around doping. Who would take the risk to play with fire and risk the reputation of themselves, their sponsors and their sport? The Tour de France was almost swept away by the 1998 storm.

"I hope that in three weeks the image and reputation of the Tour de France is restored and your fine sport will have the merit once again it deserves."

EPO, or erythropoetin, enhances endurance by increasing the production of oxygen-rich, red blood cells in the body. The hormone has been rife in cycling since the early 1990s.

The new urine test is important because it can directly detect the hormone. Racers currently face blood tests to count red blood cells, and face suspensions if counts come in over a 50-percent level. The blood test is a not a direct test of the presence of EPO, and riders who are suspended are done so for "health reasons."

Nevertheless, there are whispers that cyclists already have moved on to other non-detectable performance enhancing drugs, such as human growth hormones and a hormone that increases the amount of hemoglobin in the blood, mimicking the effects of EPO.

Andrew Hood is a freelance writer based in Spain. This will be his fifth Tour de France.
 



ALSO SEE
EPO tests to be saved

Lance Armstrong preview